BIT 5.26% 2.0¢ biotron limited

Ann: BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,655 Posts.
    lightbulb Created with Sketch. 550
    Hi cbert,

    Just for clarification, when you say "Getting into Phase 2 is definitely a major milestone and as such price sensitive", I'm not really sure what you mean. This particular trial started months ago. More importantly this isn't the first phase 2 HIV trial for BIT-225. The current trails BIT225-010 and BIT225-011 and the 2nd and 3rd phase 2 trials for HIV. You might take a peek back at 2018 and look at the BIT225-009 phase 2 HIV trial for BIT225.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.001(5.26%)
Mkt cap ! $18.04M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $9.288K 460.4K

Buyers (Bids)

No. Vol. Price($)
1 15038 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 24000 1
View Market Depth
Last trade - 15.05pm 07/11/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.